GlassScriptPhysician profile
Joshua J Boone
NPI 1598907537
$6,845.80
in general payments reported to CMS, 2019-2025
17 companies · $2,052 in 2025
The $2,052 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $1,261 · 2021: $640 · 2022: $659 · 2023: $1,657 · 2024: $437 · 2025: $2,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,192 · Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,192.26 |
| Food and Beverage | $954.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,038.28 | 2021-2025 | Prostep, Prostep Mica, Infinity |
| Arthrex, INC. | $1,848.39 | 2020-2023 | |
| Trilliant Surgical LLC. | $903.32 | 2020-2021 | |
| Titan Surgical Group, LLC | $570.61 | 2022-2024 | |
| Wright Medical Technology, INC. | $151.53 | 2019-2020 | |
| Organogenesis INC. | $54.86 | 2021-2022 | |
| Medical Device Business Services, INC. | $43.88 | 2020 | |
| Smith+Nephew, INC. | $42.41 | 2023-2024 | Cadence, Salto Talaris Total Ankle Prosthesis, Grafix |
| Janssen Pharmaceuticals, INC | $30.60 | 2021 | |
| Abbvie INC. | $29.75 | 2022-2024 | |
| Djo, LLC | $24.89 | 2024 | Cmf |
| Heron Therapeutics, INC. | $21.90 | 2023 | Zynrelef |
| Paragon 28, INC. | $20.80 | 2020 | |
| Osiris Therapeutics INC. | $19.88 | 2019 | |
| Linvatec Corporation | $15.41 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $15.40 | 2024 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $13.89 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Boone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.